(Q34986752)

5 August 2017

Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. (English)

1 reference

genome-wide association study

5 August 2017

0 references

0 references

0 references

0 references

1 reference

Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene)

series ordinal

1

1 reference

PubMed ID

19525955

5 August 2017

language of work or name

English

0 references

publication date

14 June 2009

1 reference

5 August 2017

1 reference

5 August 2017

41

1 reference

5 August 2017

824-828

1 reference

5 August 2017

7

1 reference

PubMed ID

19525955

describes a project that uses

5 August 2017

genome-wide association study

1 reference

https://scigraph.springernature.com/pub.10.1038/ng.396

inferred from title

exact match

0 references

cites work

Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus

1 reference

12 December 2020

Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13.

1 reference

12 December 2020

1 reference

12 December 2020

Principal components analysis corrects for stratification in genome-wide association studies

1 reference

12 December 2020

Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians

1 reference

12 December 2020

1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis

1 reference

12 December 2020

1 reference

12 December 2020

A CD40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of CD40 tissue-specific expression.

1 reference

12 December 2020

Common variants at CD40 and other loci confer risk of rheumatoid arthritis

1 reference

12 December 2020

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

1 reference

12 December 2020

CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis

1 reference

12 December 2020

Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation.

1 reference

12 December 2020

Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis

1 reference

12 December 2020

Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor

1 reference

12 December 2020

A unified approach to genotype imputation and haplotype-phase inference for large data sets of trios and unrelated individuals

1 reference

12 December 2020

Haploview: analysis and visualization of LD and haplotype maps

1 reference

12 December 2020

Control of autoimmune diseases by the vitamin D endocrine system

1 reference

12 December 2020

Successful treatment of animal models of rheumatoid arthritis with small-molecule cyclin-dependent kinase inhibitors

1 reference

12 December 2020

1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis

1 reference

12 December 2020

A Graves' disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology

1 reference

12 December 2020

T cell gene expression profiling identifies distinct subgroups of Japanese multiple sclerosis patients

1 reference

12 December 2020

Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering

1 reference

12 December 2020

1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells.

1 reference

12 December 2020

The expanding genetic overlap between multiple sclerosis and type I diabetes

1 reference

12 December 2020

PLINK: a tool set for whole-genome association and population-based linkage analyses

1 reference

12 December 2020

1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation

1 reference

12 December 2020

The role of CD40 in the regulation of humoral and cell-mediated immunity

1 reference

12 December 2020

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

12 December 2020

Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes

1 reference

12 December 2020

Risk alleles for multiple sclerosis identified by a genomewide study

1 reference

12 December 2020

MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT

1 reference

12 December 2020

Cyclin-dependent kinase 4 hyperactivity promotes autoreactivity in the immune system but protects pancreatic cell mass from autoimmune destruction in the nonobese diabetic mouse model.

1 reference

12 December 2020

Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia

1 reference

12 December 2020

CD40 signaling-mediated induction of Bcl-XL, Cdk4, and Cdk6. Implication of their cooperation in selective B cell growth

1 reference

12 December 2020

Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40

1 reference

12 December 2020

Genetic association analysis of 13 nuclear-encoded mitochondrial candidate genes with type II diabetes mellitus: the DAMAGE study

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNG.396

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/NG.396

1 reference

5 August 2017

1 reference

PubMed ID

19525955